OptimizeRx Corporation’s (NASDAQ:OPRX) 33% Share Price Plunge Could Signal Some Risk
OptimizeRx Corporation (NASDAQ:OPRX) shareholders won’t be pleased to see that the share price has had a very rough month, dropping 33% and undoing the prior period’s positive performance. Of course, over the longer-term many would still wish they owned shares as the stock’s price has soared 200% in the last twelve months.
In spite of the heavy fall in price, there still wouldn’t be many who think OptimizeRx’s price-to-sales (or “P/S”) ratio of 2.5x is worth a mention when the median P/S in the United States’ Healthcare Services industry is similar at about 2.6x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment….
